Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures

Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures

New PROFINET-enabled pumps from Watson-Marlow enable seamless integration of fluid delivery up to enterprise-level

Watson-Marlow Fluid Technology Group (WMFTG) is extending its industrial Ethernet control offer by making PROFINET available on its 530, 630 and 730 series of cased peristaltic pumps. This additional communication capability allows customers to access fast, accurate performance data and seamless connectivity with modern PLC control systems and the Internet of Things (IoT) using either EtherNet/IP™ or PROFINET®.

University of Miami Medical Researchers Accelerate Future of Personalized Wellness with the MILBox Project

Researchers at the University of Miami have unveiled a groundbreaking research project called the MILBox, which uses AI to create “digital twins” of patients. Once created, healthcare practitioners can test and evaluate various treatment options and potential outcomes on these “digital twins,” before applying them in the physical world. The study is supported by Amazon Web Services and Open Health Network, which use data from wearables and in-home sensors to create these “digital twins."

QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS® PLATFORM

MetaboParis-Santé platform first in France to install Bruker In Vitro Diagnostic research by NMR* system at Université de Paris

Université de Paris has installed new Bruker In Vitro Diagnostic research (IVDr) nuclear magnetic resonance (NMR) spectrometer within its MetaboParis-Santé platform located in the center of Paris city, France.

Parkinson’s UK and Domainex collaborate to develop therapies targeting neuroinflammation to slow the progression of Parkinson’s

Parkinson’s UK, the largest charitable funder of Parkinson’s research in Europe, and Domainex Ltd., today announce a collaboration focused on developing small molecule therapies targeting neuroinflammation that could slow the progression of Parkinson’s.

Science 37® and PhysIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, and physIQ Inc, a leader in digital medicine, today announced a collaboration to help research sponsors use remote biosensors and machine learning to build more robust data sets. This will help increase the number of digital biomarkers and generate insights from continuous data streams to more quickly and objectively demonstrate the safety and efficacy of treatments.

mdgroup Newly Appointed Medical Director Dr Arthur Lazarus Addresses Remote Patient Healthcare Selection at SCOPE 2022

‘Double Agent’ in Healthcare Industry Will Promote a Truly Patient-Centric Agenda Bracknell, UK - 3 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director. Dr Lazarus will also be speaking at SCOPE 2022 on Thursday 10th February,11.30am ET, discussing how proper selection of healthcare providers for remote patient visits improves data integrity and monitoring. He will be sharing how the latest medical technologies meet patient care to create remarkable patient experiences, and the important factors to consider when selecting Healthcare Professionals for mobile health patient visits.

Qlucore appoints new Head of R&D

Qlucore appoints new Head of R&D

Kyruus Announces Record-Breaking Customer Growth in 2021, Welcoming HealthSparq and Connecting Millions of People with Care

Leading Digital Health Company Expands Provider and Payer Customer Base as Demand for Patient Access Solutions Accelerates Across the Healthcare Industry

DFE Pharma appoints Martti Hedman as new CEO

DFE Pharma appoints Martti Hedman as new CEO The combination of his experience, culture and drive makes him an ideal fit for DFE Pharma for the next stages of growth Goch, Germany (7th February 2022) – DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, today announced that Martti Hedman has been appointed as the new Chief Executive Officer. An experienced business leader, Hedman will succeed Bas van Driel and assume responsibilities on 14th February. Van Driel decided to step down in order to allow the company to further grow after setting the company up for success.

Rho Clinical Development Expert Available for One-on-one Discussions at the 14th Annual Outsourcing in Clinical Trials West Coast

Rho, a full-service contract research organization (CRO), is sharing its clinical development expertise with attendees of the 14th Annual Outsourcing in Clinical Trials (OCT) West Coast conference, taking place at the Hyatt Regency San Francisco Airport from February 15-16, 2022. Rho’s Associate Director of Business Development Brennan Munley is offering one-on-one meetings with those interested in learning more about how Rho can help ensure an efficient and a successful drug development process.

DuPont invests in bioprocessing supply chain to enhance purchasing of its products for drug development

DuPont has launched a new online sales portal tailored to the needs of bioprocessing industry purchasers. The portal handles online sales transactions, with target lead times of < 1 week.

Lyniate Earns Best in KLAS® Distinction for Integration Engine Category

BioSkryb Genomics and ALS Automated Lab Solutions GmbH Sign U.S. Distribution Agreement to Power Unprecedented Single Cell Spatial Genomics

BioSkryb Genomics, a leader of single-cell genome amplification, and ALS Automated Lab Solutions GmbH, developers of a multi-patented spatial single cell and colony picking technology platform, today announced a U.S. distribution agreement to power comprehensive single cell plus spatial genomic analysis.

ZeOmega Named #1 Best in KLAS Top Performer for Payer Care Management Solutions 2022

Curebase Joins the SCRS Global Impact Partner Program

Curebase Joins the SCRS Global Impact Partner Program

New Genetic Analyzer Brings Advanced Capabilities to Sanger Sequencing and Fragment Analysis

Hello, Today, Thermo Fisher announced a new addition to its leading Applied Biosystems portfolio: a genetic analyzer that customers say is “the most intuitive and flexible sequencer we have ever used.” The Applied Biosystems SeqStudio Flex Series Genetic Analyzer builds on leading CE-technology to support customers performing Sanger sequencing or fragment analysis. Please find the press release below and online here and let me know if you have any questions or would like a high-res product photo.

PubHive Adds Single Sign-On Integration With Okta

New integration facilitates secure single sign-on (SSO) and user provisioning for life science companies using PubHive’s AI-powered scientific workflow automation SaaS platform

Alfa Chemistry Demonstrates Ability for Surface Analysis to Facilitate Materials Testing for Alternative Energy Industry